Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-04-10 @ 12:25 AM
Study NCT ID:
NCT00984360
Status:
COMPLETED
Last Update Posted:
2013-05-31
First Post:
2009-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Naltrexone for Methamphetamine Addiction
Sponsor:
California Pacific Medical Center Research Institute
Organization:
Study Overview
Official Title:
A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: